Indivior PLC (OTCMKTS:INVVY – Get Free Report) crossed below its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares trading hands.
Indivior Stock Down 1.8%
The company has a market capitalization of $3.01 billion, a PE ratio of 20.81 and a beta of 0.35. The stock has a 50-day moving average of $21.85 and a 200 day moving average of $21.85.
Indivior Company Profile
Indivior plc is a specialty pharmaceutical company focused on developing and commercializing medicines for substance use disorders and other behavioral health conditions. Its portfolio includes treatments for opioid use disorder, opioid overdose, alcohol use disorder and schizophrenia.
The company’s products include Sublocade, an extended-release buprenorphine injection for opioid use disorder; Suboxone, a buprenorphine and naloxone treatment available in film and tablet formulations; and Opvee, a nalmefene nasal spray designed to reverse opioid overdose.
Recommended Stories
- Five stocks we like better than Indivior
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}
